# AEG35156 and Docetaxel in Treating Patients With Solid Tumors

> **NCT00357747** · PHASE1 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 10 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** AEG35156
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00357747
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06-09
- **Primary completion:** 2006-09-26
- **Final completion:** 2010-06-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00357747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00357747, "AEG35156 and Docetaxel in Treating Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00357747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*